• 6769 Citations
  • 39 Scopus h-Index
1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1986 2019

  • 6769 Citations
  • 39 Scopus h-Index
  • 111 Article
  • 7 Review article
  • 4 Letter
  • 2 Comment/debate
2019
1 Citation (Scopus)

Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group

Casey, D. L., Chi, Y. Y., Donaldson, S. S., Hawkins, D. S., Tian, J., Arndt, C. A. S., Rodeberg, D. A., Routh, J. C., Lautz, T. B., Gupta, A. A., Yock, T. I. & Wolden, S. L., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
irinotecan
Vincristine
Alveolar Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma

On the First Usage of the Term “Rhabdomyosarcoma”

Raney, R. B., Arndt, C. A. S. & Parham, D. M., Jan 1 2019, In : Pediatric and Developmental Pathology. 22, 1, 1 p.

Research output: Contribution to journalLetter

Rhabdomyosarcoma
5 Citations (Scopus)

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Smeland, S., Bielack, S. S., Whelan, J., Bernstein, M., Hogendoorn, P., Krailo, M. D., Gorlick, R., Janeway, K. A., Ingleby, F. C., Anninga, J., Antal, I., Arndt, C. A. S., Brown, K. L. B., Butterfass-Bahloul, T., Calaminus, G., Capra, M., Dhooge, C., Eriksson, M., Flanagan, A. M., Friedel, G. & 32 others, Gebhardt, M. C., Gelderblom, H., Goldsby, R., Grier, H. E., Grimer, R., Hawkins, D. S., Hecker-Nolting, S., Sundby Hall, K., Isakoff, M. S., Jovic, G., Kühne, T., Kager, L., von Kalle, T., Kabickova, E., Lang, S., Lau, C. C., Leavey, P. J., Lessnick, S. L., Mascarenhas, L., Mayer-Steinacker, R., Meyers, P. A., Nagarajan, R., Randall, R. L., Reichardt, P., Renard, M., Rechnitzer, C., Schwartz, C. L., Strauss, S., Teot, L., Timmermann, B., Sydes, M. R. & Marina, N., Mar 1 2019, In : European Journal of Cancer. 109, p. 36-50 15 p.

Research output: Contribution to journalArticle

Osteosarcoma
Cohort Studies
Confidence Intervals
Survival
Neoplasm Metastasis
2018
10 Citations (Scopus)

Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: A report from the children’s oncology group

Hawkins, D. S., Chi, Y. Y., Anderson, J. R., Tian, J., Arndt, C. A. S., Bomgaars, L., Donaldson, S. S., Hayes-Jordan, A., Mascarenhas, L., Mccarville, M. B., Mccune, J. S., Mccowage, G., Million, L., Morris, C. D., Parham, D. M., Rodeberg, D. A., Rudzinski, E. R., Shnorhavorian, M., Spunt, S. L., Skapek, S. X. & 4 others, Teot, L. A., Wolden, S., Yock, T. I. & Meyer, W. H., Sep 20 2018, In : Journal of Clinical Oncology. 36, 27, p. 2770-2777 8 p.

Research output: Contribution to journalArticle

irinotecan
Rhabdomyosarcoma
Dactinomycin
Vincristine
Cyclophosphamide
1 Citation (Scopus)

Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned

Arndt, C. A. S., Bisogno, G. & Koscielniak, E., Jul 1 2018, In : Cancer Treatment Reviews. 68, p. 94-101 8 p.

Research output: Contribution to journalReview article

Rhabdomyosarcoma
Alkylating Agents
Drug Therapy
Ifosfamide
Dactinomycin
1 Citation (Scopus)

Hyperbaric oxygen as a treatment modality in cyclophosphamide-induced hemorrhagic cystitis

Kaur, D., Khan, S. P., Rodriguez, V., Arndt, C. A. S. & Claus, P., Jan 1 2018, (Accepted/In press) In : Pediatric Transplantation.

Research output: Contribution to journalArticle

Cystitis
Cyclophosphamide
Oxygen
Urinary Bladder
Acrolein
1 Citation (Scopus)

Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups

Minard-Colin, V., Walterhouse, D., Bisogno, G., Martelli, H., Anderson, J., Rodeberg, D. A., Ferrari, A., Jenney, M., Wolden, S., De Salvo, G., Arndt, C. A. S., Merks, J. H. M., Gallego, S., Schwob, D., Haie-Meder, C., Bergeron, C., Stevens, M. C. G., Oberlin, O. & Hawkins, D., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Radiotherapy
Sarcoma
Brachytherapy
Pediatrics
2017
7 Citations (Scopus)

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML

Gore, L., Triche, T. J., Farrar, J. E., Wai, D., Legendre, C., Gooden, G. C., Liang, W. S., Carpten, J., Lee, D., Alvaro, F., Macy, M. E., Arndt, C. A. S., Barnette, P., Cooper, T., Martin, L., Narendran, A., Pollard, J., Meshinchi, S., Boklan, J., Arceci, R. J. & 1 others, Salhia, B., Oct 5 2017, In : Clinical Epigenetics. 9, 1, 108.

Research output: Contribution to journalArticle

decitabine
Induction Chemotherapy
Epigenomics
Multicenter Studies
Bone Marrow
1 Citation (Scopus)

A Severe Case of Congenital Thrombotic Thrombocytopenia Purpura Resulting From Compound Heterozygosity Involving a Novel ADAMTS13 Pathogenic Variant

Conboy, E., Partain, P. I., Warad, D., Kluge, M. L., Arndt, C. A. S., Chen, D. & Rodriguez, V., Jul 3 2017, (Accepted/In press) In : Journal of Pediatric Hematology/Oncology.

Research output: Contribution to journalArticle

Purpura
Thrombocytopenia
Thrombotic Thrombocytopenic Purpura
Nonsense Codon
Heterozygote

Cetirizine-responsive, persistent idiopathic eosinophilia in a nonatopic child

Knight, E., Fischer, P., Arndt, C. A. S., Anim, S. & Joshi, A., Feb 1 2017, In : Annals of Allergy, Asthma and Immunology. 118, 2, p. 230-231 2 p.

Research output: Contribution to journalArticle

Cetirizine
Eosinophilia
3 Citations (Scopus)

Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy

Paludo, J., Fritchie, K., Haddox, C. L., Rose, P. S., Arndt, C. A. S., Marks, R. S., Galanis, E., Okuno, S. H. & Robinson, S., Jun 15 2017, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

Osteosarcoma
Drug Therapy
Platinum
Disease-Free Survival
Survival
2 Citations (Scopus)

Management of pediatric hepatocellular carcinoma: A multimodal approach

Kohorst, M. A., Warad, D. M., Matsumoto, J. M., Heimbach, J. K., El-Youssef, M., Arndt, C. A. S., Rodriguez, V. & Nageswara Rao, A. A., 2017, (Accepted/In press) In : Pediatric Transplantation.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Pediatrics
Transplants
Liver Transplantation
Doxorubicin
4 Citations (Scopus)

Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group

Gupta, A. A., Chi, Y. Y., Anderson, J. R., Lyden, E., Weigel, B., Arndt, C. A. S., Meyer, W. H., Rosenberg, A. & Hawkins, D. S., 2017, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Disease-Free Survival
Drug Therapy
Alveolar Rhabdomyosarcoma
Confidence Intervals
3 Citations (Scopus)

Pelvis Ewing sarcoma: Local control and survival in the modern era

Ahmed, S. K., Robinson, S., Arndt, C. A. S., Petersen, I. A., Haddock, M., Rose, P. S. & Laack, N. N., 2017, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Pelvis
Radiation
Survival
Incidence
2016
73 Citations (Scopus)

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C. A. S., van den Berg, H., Brennan, B., Brichard, B., Brown, K. L. B., Butterfass-Bahloul, T., Calaminus, G., Daldrup-Link, H. E., Eriksson, M., Gebhardt, M. C., Gelderblom, H., Gerss, J., Goldsby, R. & 33 others, Goorin, A., Gorlick, R., Grier, H. E., Hale, J. P., Hall, K. S., Hardes, J., Hawkins, D. S., Helmke, K., Hogendoorn, P. C. W., Isakoff, M. S., Janeway, K. A., Jürgens, H., Kager, L., Kühne, T., Lau, C. C., Leavey, P. J., Lessnick, S. L., Mascarenhas, L., Meyers, P. A., Mottl, H., Nathrath, M., Papai, Z., Randall, R. L., Reichardt, P., Renard, M., Safwat, A. A., Schwartz, C. L., Stevens, M. C. G., Strauss, S. J., Teot, L., Werner, M., Sydes, M. R. & Whelan, J. S., Oct 1 2016, In : The Lancet Oncology. 17, 10, p. 1396-1408 13 p.

Research output: Contribution to journalArticle

Ifosfamide
Etoposide
Osteosarcoma
Randomized Controlled Trials
Drug Therapy
48 Citations (Scopus)

Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patientswith high-risk rhabdomyosarcoma: A report from the children's oncology group

Weigel, B. J., Lyden, E., Anderson, J. R., Meyer, W. H., Parham, D. M., Rodeberg, D. A., Michalski, J. M., Hawkins, D. S. & Arndt, C. A. S., Jan 10 2016, In : Journal of Clinical Oncology. 34, 2, p. 117-122 6 p.

Research output: Contribution to journalArticle

irinotecan
Ifosfamide
Rhabdomyosarcoma
Vincristine
Etoposide
10 Citations (Scopus)

Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center

Modest, M. C., Garcia, J. J., Arndt, C. A. S. & Carlson, M. L., Aug 1 2016, In : Laryngoscope. 126, 8, p. 1899-1904 6 p.

Research output: Contribution to journalArticle

Langerhans Cell Histiocytosis
Temporal Bone
Recurrence
Radiation
Laryngoscopes
2015
19 Citations (Scopus)

Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Rodeberg, D. A., Wharam, M. D., Lyden, E. R., Stoner, J. A., Brown, K., Wolden, S. L., Paidas, C. N., Donaldson, S. S., Hawkins, D. S., Spunt, S. L. & Arndt, C. A. S., Jul 1 2015, In : International Journal of Cancer. 137, 1, p. 204-211 8 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Sarcoma
Radiotherapy
Extremities
Urinary Bladder
19 Citations (Scopus)

Local control for intermediate-risk rhabdomyosarcoma: Results from D9803 according to histology, group, site, and size: A report from the children's oncology group

Wolden, S. L., Lyden, E. R., Arndt, C. A. S., Hawkins, D. S., Anderson, J. R., Rodeberg, D. A., Morris, C. D. & Donaldson, S. S., Dec 1 2015, In : International Journal of Radiation Oncology Biology Physics. 93, 5, p. 1071-1076 6 p.

Research output: Contribution to journalArticle

histology
Rhabdomyosarcoma
Histology
tumors
Alveolar Rhabdomyosarcoma
11 Citations (Scopus)

Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing Sarcoma

Stish, B. J., Ahmed, S. K., Rose, P. S., Arndt, C. A. S. & Laack, N. N., Dec 1 2015, In : Pediatric Blood and Cancer. 62, 12, p. 2189-2196 8 p.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Survivors
Quality of Life
Lower Extremity
Extremities
2014
4 Citations (Scopus)

Age-related toxicity in patients with rhabdomyosarcoma: A report from the children's oncology group

Altaf, S., Enders, F. T., Lyden, E., Donaldson, S. S., Rodeberg, D. & Arndt, C. A. S., Nov 8 2014, In : Journal of Pediatric Hematology/Oncology. 36, 8, p. 599-604 6 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Vincristine
Age Groups
Mucositis
Cyclophosphamide
Ewing's Sarcoma
Recurrence
Survival Rate
Survival
Statistical Factor Analysis
13 Citations (Scopus)

Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group

Rosenberg, A. R., Anderson, J. R., Lyden, E., Rodeberg, D. A., Wolden, S. L., Kao, S. C., Parham, D. M., Arndt, C. A. S. & Hawkins, D. S., Mar 2014, In : European Journal of Cancer. 50, 4, p. 816-823 8 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Survival
Histology
Magnetic Resonance Imaging
Therapeutics
7 Citations (Scopus)

Membranous nephropathy associated with angiomatoid fibrous histiocytoma in a pediatric patient

Kohorst, M. A., Tran, C. L., Folpe, A. L., Sethi, S. M. & Arndt, C. A. S., Nov 1 2014, In : Pediatric nephrology (Berlin, Germany). 29, 11, p. 2221-2224 4 p.

Research output: Contribution to journalArticle

Membranous Glomerulonephritis
Pediatrics
Nephrotic Syndrome
Paraneoplastic Syndromes
Neoplasms
5 Citations (Scopus)

Minimally invasive treatment of a painful osteolytic lumbar lesion secondary to epithelioid hemangioendothelioma

Sebastian, A. S., Adair, M. J., Morris, J. M., Khan, M. H., Arndt, C. A. S. & Nassr, A., Aug 6 2014, In : Global Spine Journal. 5, 2, p. 135-139 5 p.

Research output: Contribution to journalArticle

Epithelioid Hemangioendothelioma
Spine
Combined Modality Therapy
Cryosurgery
Diphosphonates
1 Citation (Scopus)

Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma"

Altaf, S., Enders, F. T., Krailo, M., Barkauskas, D., Meyers, P. & Arndt, C. A. S., 2014, In : Pediatric Blood and Cancer. 61, 5, p. 951 1 p.

Research output: Contribution to journalArticle

Bone Neoplasms
Osteosarcoma
Body Mass Index
Obesity
Survival
20 Citations (Scopus)

Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma

Brown, L. C., Lester, R. A., Grams, M. P., Haddock, M., Olivier, K. R., Arndt, C. A. S., Rose, P. S. & Laack, N. N., Dec 8 2014, In : Sarcoma. 2014, 418270.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Radiosurgery
Osteosarcoma
Spontaneous Fractures
Disease-Free Survival
2013
13 Citations (Scopus)

Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group soft tissue sarcoma committee

Burke, M. E., Lyden, E. R., Meza, J. L., Ladas, E. J., Dasgupta, R., Wiegner, E. A. & Arndt, C. A. S., May 2013, In : Pediatric Blood and Cancer. 60, 5, p. 748-753 6 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Sarcoma
Weight Loss
Body Mass Index
Weights and Measures
16 Citations (Scopus)

High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: A report from the Children's Oncology Group

Altaf, S., Enders, F. T., Jeavons, E., Krailo, M., Barkauskas, D. A., Meyers, P. & Arndt, C. A. S., Dec 2013, In : Pediatric Blood and Cancer. 60, 12, p. 2042-2046 5 p.

Research output: Contribution to journalArticle

Osteosarcoma
Body Mass Index
Survival
Logistic Models
Weights and Measures
7 Citations (Scopus)
Rhabdomyosarcoma
Histology
Lymph Nodes
Outcome Assessment (Health Care)
Drug Therapy
18 Citations (Scopus)

The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: An analysis of IRS-IV and D9803

Spalding, A. C., Hawkins, D. S., Donaldson, S. S., Anderson, J. R., Lyden, E., Laurie, F., Wolden, S. L., Arndt, C. A. S. & Michalski, J. M., Nov 1 2013, In : International Journal of Radiation Oncology Biology Physics. 87, 3, p. 512-516 5 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Radiation Effects
time measurement
nerves
Skull Base
2012
122 Citations (Scopus)

Common musculoskeletal tumors of childhood and adolescence

Arndt, C. A. S., Rose, P. S., Folpe, A. L. & Laack, N. N., 2012, In : Mayo Clinic Proceedings. 87, 5, p. 475-487 13 p.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Rhabdomyosarcoma
Osteosarcoma
Neoplasms
Radiation Oncology
30 Citations (Scopus)

Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803 - A report from the children's oncology group

Lin, C., Donaldson, S. S., Meza, J. L., Anderson, J. R., Lyden, E. R., Brown, C. K., Morano, K., Laurie, F., Arndt, C. A. S., Enke, C. A. & Breneman, J. C., Apr 1 2012, In : International Journal of Radiation Oncology Biology Physics. 82, 5, p. 1764-1770 7 p.

Research output: Contribution to journalArticle

Intensity-Modulated Radiotherapy
Rhabdomyosarcoma
radiation therapy
Radiotherapy
Survival
27 Citations (Scopus)

The clinical case for proton beam therapy

Foote, R. L., Stafford, S. L., Petersen, I. A., Pulido, J. S., Clarke, M. J., Schild, S. E., Garces, Y. I., Olivier, K. R., Miller, R. C., Haddock, M., Yan, E., Laack, N. N., Arndt, C. A. S., Buskirk, S. J., Miller, V. L., Brent, C. R., Kruse, J. J., Ezzell, G. A., Herman, M. G., Gunderson, L. L. & 2 others, Erlichman, C. & Diasio, R. B., Oct 22 2012, In : Radiation Oncology. 7, 1, 174.

Research output: Contribution to journalArticle

Proton Therapy
Costs and Cost Analysis
Protons
Radiotherapy
Therapeutics
2011
46 Citations (Scopus)

Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee

Rodeberg, D. A., Anderson, J. R., Arndt, C. A. S., Ferrer, F. A., Raney, R. B., Jenney, M. E., Brecht, I. B., Koscielniak, E., Carli, M., Bisogno, G., Oberlin, O., Rey, A., Ullrich, F., Stevens, M. C. G. & Meyer, W. H., Mar 1 2011, In : International Journal of Cancer. 128, 5, p. 1232-1239 8 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Sarcoma
Prostate
Urinary Bladder
Pediatrics
26 Citations (Scopus)

Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology Group

Langholz, B., Skolnik, J. M., Barrett, J. S., Renbarger, J., Seibel, N. L., Zajicek, A. & Arndt, C. A. S., Aug 2011, In : Pediatric Blood and Cancer. 57, 2, p. 252-257 6 p.

Research output: Contribution to journalArticle

Dactinomycin
Vincristine
Retrospective Studies
Neoplasms
Body Size
41 Citations (Scopus)

Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group

Walterhouse, D. O., Meza, J. L., Breneman, J. C., Donaldson, S. S., Hayes-Jordan, A., Pappo, A. S., Arndt, C. A. S., Raney, R. B., Meyer, W. H. & Hawkins, D. S., Jul 15 2011, In : Pediatric Blood and Cancer. 57, 1, p. 76-83 8 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Sarcoma
Radiotherapy
Recurrence
Vagina
2 Citations (Scopus)

Postradiation dermatofibrosarcoma protuberans in a patient with Wilms tumor

Kumar, R., Rodriguez, V., Khan, S. P., Laack, N. N. & Arndt, C. A. S., Dec 2011, In : Journal of Pediatric Hematology/Oncology. 33, 8, p. 635-636 2 p.

Research output: Contribution to journalArticle

Radiation-Induced Neoplasms
Dermatofibrosarcoma
Wilms Tumor
Kidney Neoplasms
Chemoradiotherapy
27 Citations (Scopus)

Rhabdomyosarcoma in infants younger than 1 year: A report from the children's oncology group

Malempati, S., Rodeberg, D. A., Donaldson, S. S., Lyden, E. R., Anderson, J. R., Hawkins, D. S. & Arndt, C. A. S., Aug 1 2011, In : Cancer. 117, 15, p. 3493-3501 9 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Confidence Intervals
Treatment Failure
Sarcoma
Survival Rate
8 Citations (Scopus)

Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: A report from the children's oncology group

Rodeberg, D. A., Stoner, J. A., Garcia-Henriquez, N., Randall, R. L., Spunt, S. L., Arndt, C. A. S., Kao, S., Paidas, C. N., Million, L. & Hawkins, D. S., Jun 1 2011, In : Cancer. 117, 11, p. 2541-2550 10 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Tumor Burden
Weights and Measures
Disease-Free Survival
Neoplasms
2010
105 Citations (Scopus)

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin b for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia

Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Wise, B. A., Strohmaier, K. M., Taylor, A. F., Kartsonis, N. A., Chow, J. W., Arndt, C. A. S., Depauw, B. E. & Walsh, T. J., May 2010, In : Pediatric Infectious Disease Journal. 29, 5, p. 415-420 6 p.

Research output: Contribution to journalArticle

caspofungin
Amphotericin B
Neutropenia
Double-Blind Method
Multicenter Studies
18 Citations (Scopus)

Early treatment failure in intermediate-risk rhabdomyosarcoma: Results from IRS-IV and D9803 - A report from the Children's Oncology Group

Minn, A. Y., Lyden, E. R., Anderson, J. R., Million, L., Arndt, C. A. S., Brown, K., Hawkins, D. S. & Donaldson, S. S., Sep 20 2010, In : Journal of Clinical Oncology. 28, 27, p. 4228-4232 5 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Treatment Failure
Radiotherapy
Induction Chemotherapy
Survival
17 Citations (Scopus)

Impact of tumor viability at second-look procedures performed before completing treatment on the Intergroup Rhabdomyosarcoma Study Group protocol IRS-IV, 1991-1997: A report from the children's oncology group

Raney, B., Stoner, J., Anderson, J., Andrassy, R., Arndt, C. A. S., Brown, K., Crist, W., Maurer, H., Qualman, S., Wharam, M., Wiener, E., Meyer, W. & Hayes-Jordan, A., Nov 2010, In : Journal of Pediatric Surgery. 45, 11, p. 2160-2168 9 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Neoplasms
Therapeutics
Survival
Survival Rate
46 Citations (Scopus)

Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: Effects on disease-free survival and immunomodulation. A report from the Children's Oncology Group

Arndt, C. A. S., Koshkina, N. V., Inwards, C. Y., Hawkins, D. S., Krailo, M. D., Villaluna, D., Anderson, P. M., Goorin, A. M., Blakely, M. L., Bernstein, M., Bell, S. A., Ray, K., Grendahl, D. C., Marina, N. & Kleinerman, E. S., Aug 1 2010, In : Clinical Cancer Research. 16, 15, p. 4024-4030 7 p.

Research output: Contribution to journalArticle

Immunomodulation
Osteosarcoma
Granulocyte-Macrophage Colony-Stimulating Factor
Disease-Free Survival
Recurrence

Reply

Walsh, T. J., Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Ann Wise, B., Strohmaier, K. M., Taylor, A. F., Kartsonis, N. A., Chow, J. W., Arndt, C. A. S. & Depauw, B. E., Oct 2010, In : Pediatric Infectious Disease Journal. 29, 10, p. 986-987 2 p.

Research output: Contribution to journalLetter

2009
177 Citations (Scopus)

Dose-intensified compared with standard chemotherapy for nonmetastatic ewing sarcoma family of tumors: A children's oncology group study

Granowetter, L., Womer, R., Devidas, M., Krailo, M., Wang, C., Bernstein, M., Marina, N., Leavey, P., Gebhardt, M., Healey, J., Shamberger, R. C., Goorin, A., Miser, J., Meyer, J., Arndt, C. A. S., Sailer, S., Marcus, K., Perlman, E., Dickman, P. & Grier, H. E., May 20 2009, In : Journal of Clinical Oncology. 27, 15, p. 2536-2541 6 p.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Drug Therapy
Vincristine
Ifosfamide
Doxorubicin
24 Citations (Scopus)

Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma

Imran, H., Enders, F. T., MarkKrailo, Sim, F., Okuno, S. H., Hawkins, D., Neglia, J., Randall, R. L., Womer, R., Mascarenhas, L. & Arndt, C. A. S., Mar 1 2009, In : Journal of Bone and Joint Surgery - Series A. 91, 3, p. 604-612 9 p.

Research output: Contribution to journalArticle

Osteosarcoma
Drug Therapy
Extremities
Proportional Hazards Models
Tertiary Care Centers
161 Citations (Scopus)

Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group Study D9803

Arndt, C. A. S., Stoner, J. A., Hawkins, D. S., Rodeberg, D. A., Hayes-Jordan, A. A., Paidas, C. N., Parham, D. M., Teot, L. A., Wharam, M. D., Breneman, J. C., Donaldson, S. S., Anderson, J. R. & Meyer, W. H., Nov 1 2009, In : Journal of Clinical Oncology. 27, 31, p. 5182-5188 7 p.

Research output: Contribution to journalArticle

Topotecan
Rhabdomyosarcoma
Dactinomycin
Vincristine
Cyclophosphamide
2008
21 Citations (Scopus)
Ifosfamide
Rhabdomyosarcoma
Vincristine
Etoposide
Doxorubicin
3 Citations (Scopus)

Congenital angiosarcoma with transient response to paclitaxel

Good, A. B., Nascimento, A., Welker, K. M. & Arndt, C. A. S., Jun 2008, In : Journal of Pediatric Hematology/Oncology. 30, 6, p. 451-453 3 p.

Research output: Contribution to journalArticle

Hemangiosarcoma
Paclitaxel